The Role of Fungi in Pharmaceutical Biotechnology
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biologics and Biosimilars".
Deadline for manuscript submissions: closed (20 February 2022) | Viewed by 6732
Special Issue Editors
Interests: microbiology (bacteria, viruses, fungi, parasites); microbiology and laboratory in public health; antibiotics (all linked with this matter); immunology; surveillance; epidemiology; drug discovery; drug design; medicinal chemistry; bacteriophages; biofilms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biopharmaceuticals are an important and continuously growing class of pharmaceuticals, having found frequent use and an integral role in the treatment of many different diseases. In general, the development and production of biopharmaceuticals involves prokaryote systems; however, most often, due to the need of complex (post-translational) modifications, eukaryotic systems such a yeast or mammalian cells are used. In addition to filamentous fungi-derived pharmaceuticals, molds and fungi still play an important role in antibiotic production. More recently, fungi have been showing the highest titers for protein and peptide production, including biopharmaceuticals.
The aim of this Special Issue of Pharmaceutics is to collect research and review papers regarding products manufactured in, extracted from, or semisynthesized with the aid of fungi. We welcome articles dealing with all aspects of fungal-based biotechnology and invite researchers and drug developers to publish their original research or review articles with expert opinions and perspectives in the area of therapeutics.
Prof. Dr. Mircea Ioan Popa
Dr. Marco Casteleijn
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- fungi
- biopharmaceuticals
- biotechnology
- proteins and peptides
- nucleic acids
